Applications published 11 February 2009

Sol-gel nanostructured titanium reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis
Universidad Autonoma Metropolitana 2020987*

Compsns comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
Children's Hospital Medical Centre 2020988*

Pulmonary delivery of 1,2,5-dihydroxyvitamin D3 and co-adminstration of parathyroid hormone or calcitonin
Wisconsin Alumni Research Foundation 2020989*

Two-piece, internal-channel osmotic delivery system flow modulator
Intarcia Therapeutics 2020990*

Method of producing immunoliosomes and compsns thereof
The CBR ‚ Institute for Biomedical Research 2020992*

Solid pharmaceutical compsn of gabapentin
Combino Pharm 2020993*

Sustained release pharmaceutical dosage form containing phenylephrine
Schering-Plough Healthcare Products 2020994*

Zero-order modified release solid dosage forms
Mallinckrodt 2020995*

Method and compsns for treating hematological malignancies
Gilead Sciences 2020996*

Novel agents against prostate carcinoma
DSM ‚ IP 2020997*

Compsns and methods for the inhibition of endothelial nitric oxide synthase activity
University of Utah Research Foundation 2020998*

Compsns comprising alpha-ketoglutarate and their use for modulating muscle performance
SGP ‚ ‚ Sons 2020999*

Neurogenesis by modulating angiotensin
Braincells 2021000*

Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
Helicon Therapeutics 2021001*

Pharmaceutical compsn
Lek Pharmaceuticals 2021002*

Imidazoazephinone compounds
Eisai R&D ‚ Management 2021003*

Substituted azaspiro derivatives
Neurogen 2021004*

Methods and compsn for treatment of inflammatory pain
CNSBIO 2021005*

Use of flibanserin for the treatment of post-menopausal sexual desire disorders
Boehringer Ingelheim International 2021006*

Patch for the treatment of the cellulite and localised adiposity
Vitrupharma 2021007*

Stabilised immune modulatory RNA ‚ (SIMRA) ‚ compounds for TLR7 and TLR8
Idera Pharmaceutical 2021008*

Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure
Weiss, Robert; Champion, Hunter 2021009*

Condensation products, method for their production and use thereof production and use thereof in medicaments, as disinfectants or as a tannin
BASF ‚ SE 2021010*

Methods of use and nutritional compsns of touchi extract
Nestec; Novartis Pharma 2021011*

Combination of amino acid solution and a gelatin derivative for inhibiting renal uptake
BioSynthema 2021012*

Tracheal cytotoxin (TCT) and related compounds for suppressing immune responses
The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin 2021013*

Sustained release GLP-1 receptor modulators
Bristol-Myers Squibb 2021014*

Ghrelin/growth hormone releasing peptide/growth hormone secretagogue receptor antagonists and uses thereof
The Administrators of the Tulane Educational Fund 2021015*

CXCL-13 antagonists and their use for the treatment of inflammatory diseases
Centocor 2021016*

Method
GlaxoSmithKline Biologicals 2021017*

Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance
Ericson, Daniel 2021018*

Identification of CDKI ‚ pathway inhibitors
Senex Biotechnology 2021019*

Secreted campylobacter flagella coregulated proteins as immunogens
The United States of America, as represented by the Secretary of the Navy 2021020*

Anthrax compsns and methods of use and production
Oklahoma Medical Research Foundation 2021021*

Apparatus, methods and systems for toxin delivery to the nasal cavity
The Foundry 2021022*

Myxoma virus mutants for cancer treatment
Robards Research Institute 2021023*

Nicotine-carrier vaccine formulation
Cytos Biotechnology 2021024*

Method and means for treating inflammatory bowel disease
Ibd Column Therapies International 2021025*

Use of IL-1 antibodies for treating ophthalmic disorders
Novartis; Novartis Pharma 2021026*

Immunoglobulin associated cell-surface determinants in the treatment of B-cell disorders
Guthrie Foundation for Education ‚ Research 2021027*

Methods and compsns for modulation of blood-neural barrier
Ludwig Institute for Cancer Research 2021028*

Humanised FC ‚ RIIB-specific antibodies and methods of use thereof
MacroGenics 2021029*

Buffering agents for biopharmaceutical formulations
Amgen 2021030*

Hydrogel sheet and production method thereof
Shin-Etsu Chemical 2021031*

PEG-modulated argnine/lysine oxidoreductase
APIT ‚ Laboratories 2021032*

IL-1 immunisation induces autoantibodies protective against atherosclerosis
XBiotech 2021033*

An isolated DNA ‚ fragment of the human A33 promoter and its use to control the expression of a heterologous gene in tumour cells
Inis Biotech 2021034*

Cell-matrix microspheres, methods of for preparation and applications
The University of Hong Kong 2021035*

Biomarker generator system
Advanced Biomarker Technologies 2021036*

Process for the preparation of a ready-to-use disinfectant
EI ‚ du Pont de Nemours 2021037*

Biomarkers for diagnosing multiple sclerosis, and methods thereof
Phenomenome Discoveries 2021313*

Substituted biphenyl carboxylic acids and derivatives thereof
Ortho-McNeil Pharmaceutical; Cellzome 2021314*

Inhibition of polo-like kinases
Abbott Laboratories 2021316*

Contrast agents
GE ‚ Healthcare 2021317*

Synthesis of (S)-(+)-3-(amino-methyl)-5-methyl hexanoic acid
Teva Pharmaceutical 2021318*

2-substituted-1-alpha, 25-dihydroxy-19,26,27-trinor vitamin D analogues and uses thereof
Wisconsin Alumni Research Foundation 2021320*

2-methylene-1alpha,25-dihydroxy-18,19,21-trinor vitamin D3 and uses thereof
Wisconsin Alumni Research Foundation 2021321*

Therapeutic cyclopentane derivatives
Allergan 2021322*

Nitrated heterocyclic compounds as endothelin receptor antagonist
NicOx 2012324*

Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
AstraZeneca; Targacept 2021325*

Polymorph forms of (2S)-(4E)-N-methyl-5-(3-isopropoxypyridin)yl]-4-penten-2-amine for the treatment of central nervous system disorders
Targacept 2021326*

Antidiabetic bicyclic compounds
Merck 2021327*

Compounds and compsns as hedgehog pathway modulators
IRM ‚ LLC 2021328*

Inhibitors of C-FMS ‚ kinase
Janssen Pharmaceutica 2021329*

Benzimidazole modulators of VR1
Janssen Pharmaceutica 2021330*

2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
Glaxo Group 2021331*

Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
EOS- Ethical Oncology Science 2021333*

Synthesis and uses of pyroglutamic acid derivatives
Prodimed 2021334*

Heterocyclic compounds as inhibitors of C-FMS ‚ kinase
Janssen Pharmaceutica 2021335*

Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
Eli Lilly 2021336*

Cycloalkylamino acid derivatives and pharmaceutical compsns thereof
Pfizer Products 2021337*

Rosiglitazone hydrochloride hemihydrate
Sandoz 2021339*

Beta-amyloid PET ‚ imaging agents
The Government of the United States as represented by the Secretary of Health and Human Services 2021340*

4-amino-pyrido-3,2-e-pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
Elbion 2021341*

Imidazoasephine compounds
Eisai Research Institute of Boston 2021343*

Process for the production of tiralkylsilyl(fluorosulphonyl) difluoroacetate
EI ‚ du Pont de Nemours 2021346*

Low triphenylphosphate, high phosphorous content isopropyl phenyl phosphates with high ortho alkylation
Albemarle 2021347*

Phosphorylated A2A ‚ receptor agonists
Schrader, Juergen; Rheinische Friedrich-Wilhelms-Universitaet Bonn; Heinrich-Heine-Universitaet Duesseldorf 2021350*

Method for the synthesis of triazole-containing oligonucleotide derivatives
Centre National de la Recherche Scientifique 2021351*

Treatment of protein misfolding
The Scripps Research Institute 2021352*

Peptide substance revealing a stress protective effect, pharmaceutical compsn on its base and the method of its application
Obschestvo S Ogranichennoi Otvetstvennostya ‚¬Å“sia Peptides ‚¬Â 2021353*

N-terminally modified GLP-1 receptor modulators
Bristol-Myers Squibb 2021354*

Method of polymyxin B ‚ recovery from fermentation broth
Biotika 2021355*

HIV ‚ vaccine
Statens Serum Institut 2021356*

Cyclodipeptide synthetases and their use for synthesis of cyclo (leu-leu) cyclopeptide
Commisariat a l'Energie Atomique; Kyowa Hakko Bio; Universite Paris-Sud (Paris XI); Centre National de la Recherche Scienfitique 2021357*

Modified bacteriocins and methods for their use
Avidbiotics 2021358*

Cyclodipeptide synthetase and its use for synthesis of cyclo (TYR-Xaa) cyclodipeptides
Commisariat a l'Energie Atomique; Kyowa Hakko Bio; Universite Paris-Sud (Paris XI); Centre National de la Recherche Scientifique 2021360*

Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and related diseases
Mintz, Liat 2021365*

Production of proteins carrying oligomannose or human-like glycans in yeast and methods of uses thereof
Recopharma 2021366*

Derivatised insulin oligomers
Diabecore Medical 2021368*

Antibodies and standard for NT-proBNP and proBNP ‚ immunoassays
Hytest; Katrukha, Alexei; Seferyan, Karina; Semenov, Alexander; Tamm, Natalia; Filatov, Vladimir 2021369*

Trail receptor-binding agents and uses of the same
Beijing Cotimes Biotech 2021370*

Monoclonal antibodies specific for pancreatic endocrine, exocrine and ductal cells
Oregon Health and Science University 2021371*

Compsns and methods for modulating immune responses
ZymoGenetics 2021372*

VCAM-1 specific monoclonal antibody
Hanwa Chemical 2021373*

Biocompatible three-dimensional matrixfor the immobilisation of biological substances
Leukocare 2021374*